Literature DB >> 18287564

The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis.

Stephen C Textor1, James F Glockner, Lilach O Lerman, Sanjay Misra, Michael A McKusick, Stephen J Riederer, Joseph P Grande, S Ivan Gomez, J Carlos Romero.   

Abstract

Vascular occlusive disease poses a threat to kidney viability, but whether the events leading to injury and eventual fibrosis actually entail reduced oxygenation and regional tissue ischemia is unknown. Answering this question has been difficult because of the lack of an adequate method to assess tissue oxygenation in humans. BOLD (blood oxygen-level-dependent) magnetic resonance imaging detects changes in tissue deoxyhemoglobin during maneuvers that affect oxygen consumption, therefore this technique was used to image and analyze cortical and medullary segments of 50 kidneys in 25 subjects undergoing magnetic resonance (MR) angiography to diagnose renal artery stenosis (RAS). Magnetic rate of relaxation (R2*) positively correlates with deoxyhemoglobin levels and was therefore used as a surrogate measure of tissue oxygenation. Furosemide was administered to examine the effect of inhibiting energy-dependent electrolyte transport on tissue oxygenation in subjects with renovascular disease. In 21 kidneys with normal nephrograms, administration of furosemide led to a 20% decrease in medullary R2* (P < 0.01) and an 11.2% decrease in cortical R2*. In normal-size kidneys downstream of high-grade renal arterial stenoses, R2* was elevated at baseline, but fell after furosemide. In contrast, atrophic kidneys beyond totally occluded renal arteries demonstrated low levels of R2* that did not change after furosemide. In kidneys with multiple arteries, localized renal artery stenoses produced focal elevations of R2*, suggesting areas of deoxyhemoglobin accumulation. These results suggest that BOLD MR coupled with a method to suppress tubular oxygen consumption can be used to evaluate regional tissue oxygenation in the human kidney affected by vascular occlusive disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287564      PMCID: PMC2390957          DOI: 10.1681/ASN.2007040420

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  31 in total

1.  Visualization and quantification of renal R2* changes during water diuresis.

Authors:  Chun S Zuo; Neil M Rofsky; Houman Mahallati; Jeongsik Yu; Ming Zhang; Scott Gilbert; Franklin H Epstein
Journal:  J Magn Reson Imaging       Date:  2003-06       Impact factor: 4.813

2.  THE EFFECTS OF SALINE INFUSION ON SODIUM REABSORPTION BY THE PROXIMAL TUBULE OF THE DOG.

Authors:  J H DIRKS; W J CIRKSENA; R W BERLINER
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

3.  Functional characteristics of renovascular hypertension.

Authors:  T A STAMEY; I J NUDELMAN; P H GOOD; F N SCHWENTKER; F HENDRICKS
Journal:  Medicine (Baltimore)       Date:  1961-12       Impact factor: 1.889

Review 4.  Oxygen and renal metabolism.

Authors:  F H Epstein
Journal:  Kidney Int       Date:  1997-02       Impact factor: 10.612

Review 5.  Ischemic renal disease: an overlooked clinical entity?

Authors:  H R Jacobson
Journal:  Kidney Int       Date:  1988-11       Impact factor: 10.612

6.  BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics.

Authors:  L Hofmann; S Simon-Zoula; A Nowak; A Giger; P Vock; C Boesch; F J Frey; B Vogt
Journal:  Kidney Int       Date:  2006-04-26       Impact factor: 10.612

7.  Renal vein oxygen saturation in renal artery stenosis.

Authors:  K Nielsen; M Rehling; J H Henriksen
Journal:  Clin Physiol       Date:  1992-03

8.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

Authors:  Peter Marckmann; Lone Skov; Kristian Rossen; Anders Dupont; Mette Brimnes Damholt; James Goya Heaf; Henrik S Thomsen
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

9.  Effects of furosemide on medullary oxygenation in younger and older subjects.

Authors:  F H Epstein; P Prasad
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

10.  Kidneys in hypertensive rats show reduced response to nitric oxide synthase inhibition as evaluated by BOLD MRI.

Authors:  Luping Li; Pippa Storey; David Kim; Wei Li; Pottumarthi Prasad
Journal:  J Magn Reson Imaging       Date:  2003-06       Impact factor: 4.813

View more
  60 in total

Review 1.  Renovascular hypertension: screening and modern management.

Authors:  Iris Baumgartner; Lilach O Lerman
Journal:  Eur Heart J       Date:  2011-01-27       Impact factor: 29.983

Review 2.  Noncontrast functional MRI of the kidneys.

Authors:  Lorenzo Mannelli; Jeffrey H Maki; Sherif F Osman; Hersh Chandarana; David J Lomas; William P Shuman; Ken F Linnau; Douglas E Green; Giacomo Laffi; Miriam Moshiri
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

Review 3.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

4.  Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging.

Authors:  Tsutomu Inoue; Eito Kozawa; Hirokazu Okada; Kouichi Inukai; Shinichi Watanabe; Tomohiro Kikuta; Yusuke Watanabe; Tsuneo Takenaka; Shigehiro Katayama; Junji Tanaka; Hiromichi Suzuki
Journal:  J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 10.121

Review 5.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 6.  Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging.

Authors:  Joshua M Thurman; Natalie J Serkova
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

Review 7.  Antifibrotic therapies--emerging biomarkers as treatment end points.

Authors:  Jayant A Talwalkar
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

Review 8.  Timing and selection for renal revascularization in an era of negative trials: what to do?

Authors:  Stephen C Textor; Michael M McKusick; Sanjay Misra; James Glockner
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

Review 9.  Diagnosis and management of atherosclerotic renal artery stenosis: improving patient selection and outcomes.

Authors:  Christopher J White; Jeffrey W Olin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

Review 10.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.